Thank you.
So you're internally reallocating $200,000 to support the vaccine initiative, right?
With respect to isotopes, for some of the people dealing with cancer, there's still a shortage. Have you had input from the medical stakeholder groups regarding what you plan to do? Is it a short-term or a long-term solution? I see that you are making optimal use of the existing isotope supply. Part of the isotope supply initiative is $4.9 million, and the other part is the $1 million to deal with non-reactor-based production of medical isotopes. Is it a short-term or long-term strategy? Is it affecting the wait times of cancer patients who need the isotopes to get the scan? Where are things at on that front?